Effect of Autologous Cord Blood-mononuclear Cells Infusion on Immune Microenvironment in Infants Born Very Preterm in NICU

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 28, 2021

Primary Completion Date

August 18, 2022

Study Completion Date

August 18, 2022

Conditions
Immunomodulation Effect
Interventions
BIOLOGICAL

autologous cord blood mononuclear cells

preterm neonates less than 32 weeks are assigned to receive intravenous autologous cord blood mononuclear cells infusion (2-10×107cells/kg) within 24 hours after birth

BIOLOGICAL

normal saline

preterm neonates less than 32 weeks are assigned to receive normal saline within 24 hours after birth

Trial Locations (1)

511400

Jie Yang, Guangzhou

All Listed Sponsors
lead

Guangdong Women and Children Hospital

OTHER

NCT05087498 - Effect of Autologous Cord Blood-mononuclear Cells Infusion on Immune Microenvironment in Infants Born Very Preterm in NICU | Biotech Hunter | Biotech Hunter